This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9http://dx.doi.org/10.1034/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73039221
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована у вересні 1999 artículu científicu espublizáu en setiembre de 1999 im September 1999 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 September 1999
p:P577
wds:Q73039221-BE3CAEE9-420A-43AF-BECD-60121F49777D
wdt:P577
1999-09-01T00:00:00Z
p:P2093
wds:Q73039221-3888FD9F-534B-4F3C-A225-D199CA9DF919 wds:Q73039221-464D793A-0459-4C86-9BA9-0EF269B6DAB1
wdt:P2093
A Bircher R Kropf
rdfs:label
Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity
skos:prefLabel
Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity
schema:name
Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity
p:P50
wds:Q73039221-E8BD4EE4-4178-4EC0-B406-7679D8807211 wds:Q73039221-1370853E-FADA-41C8-ABE7-E054734FEB7A
wdt:P50
wd:Q72651113 wd:Q43088181
p:P1476
wds:Q73039221-482E8B7E-17EA-4361-8DD3-C01B8EC81220
wdt:P1476
Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity
p:P304
wds:Q73039221-07FDF0D7-30E5-44A3-A019-F22DCB2B9824
wdt:P304
999-1003
p:P31
wds:Q73039221-06334872-5AAB-421B-9F1F-8076A812C91A
wdt:P31
wd:Q13442814
p:P698
wds:Q73039221-32D629F6-443C-4382-BFA8-80752AB622C5
wdtn:P698
n12:10505466
wdt:P698
10505466
p:P1433
wds:Q73039221-A6850AEC-A5BC-4DD2-982D-61588680BA7A
wdt:P1433
wd:Q2699825
p:P433
wds:Q73039221-6EBE8AF0-39E0-41D2-A2BC-3A78145940BD
p:P478
wds:Q73039221-616165E8-F3DE-4936-B2B9-7FE9A31AC82B
wdt:P433
9
wdt:P478
54
p:P356
wds:Q73039221-F8C1295C-35FF-42EF-9A40-41DF34BE1822
wdtn:P356
n9:J.1398-9995.1999.00247.X
wdt:P356
10.1034/J.1398-9995.1999.00247.X